CLSA Helps Educate Assemblymembers with Life Sciences Company Tours
July 19, 2017
On July 14, 2017, CLSA partnered with Organovo, Takeda and Sanford Burnham Prebys to host a tour for members of the California Legislative Technology and Innovation Caucus.
Assemblymember Kevin Mullin (Chair, Select Committee on Biotechnology), Assemblymember Todd Gloria, staff from the offices of Assemblymembers Kevin Mullin, Evan Low, Rocky Chavez and Marie Waldron’s office were part of a group of legislators and legislative staff to join the tour.
The tour started at Organovo, where CEO, Taylor Crouch, educated the attendees about cutting edge three-dimensional bioprinting and fabrication of living human tissue that can function like native tissues. This breakthrough technology is groundbreaking, with applications ranging from speeding up the drug development process to the treatment of organ diseases.
After Organovo, CLSA took the legislators and staff on a tour of Takeda’s San Diego facility and hosted a roundtable luncheon for CLSA members and the legislators. As part of the discussion CLSA staff and member companies briefed legislators about ongoing issues of concern to the life sciences sector. Some of the issues discussed included:
- Mandatory reporting of drug prices and related proprietary information (Senate Bill 17),
- Physician education and scientific information sharing on pharmaceuticals (Senate Bill 790),
- Manufacturing and R & D tax credits,
- Sharps and pharmaceutical waste take back, particularly the state preemption of local programs,
- Science, technology, engineering, and math (STEM) education,
- Precision medicine funding,
- Connected medical devices,
- Continuous glucose monitors, and
- Affordable housing and transportation concerns.
Both Mullin and Gloria addressed the audience and pledged to provide support to advance innovation in the life sciences sector. As a native of South San Francisco, Assemblymember Mullin has close ties to the biotech cluster in that city, and is keenly aware of the value our industry provides to the state in terms of employment, economic growth, and innovation.
Assemblymember Gloria acknowledged that the biotech sector is one of the hallmarks of Assembly District 78 (San Diego region), and committed to continuing his efforts to better understand our challenges and opportunities.
Lastly, the tour of the Sanford Burnham Prebys Medical Discovery
Institute (SBP) provided a comprehensive overview of biological research and the drug discovery process. The Institute’s CEO, Dr. Perry Nisen, educated the legislators about the work SBP is doing on cancer research, neuroscience, immunity, and metabolic disorders.
This event provided a great opportunity for our members to showcase their facilities and to have a robust discussion with the legislators about the current issues facing our industry. CLSA will continue to create similar opportunities throughout the rest of 2017 and beyond to build effective relationships with elected officials at all levels of government.
For more information on CLSA’s tours and roundtables, please contact Manny Heer, Director of Alliance Development & Advocacy (email@example.com).